There’s nothing more controversial in the field of localized kidney cancer than decisions about who should get a partial and who should get a radical nephrectomy,” remarks Steven Campbell, MD, PhD, Chair of the AUA Renal Mass Guideline Panel and Vice Chairman of Urology at Cleveland Clinic.
Findings from a new study show that time-to-treatment, at least in the short term, is not significantly associated with adverse outcomes in patients with high-risk prostate cancer. Eric Klein, MD, Chair of the Glickman Urological and Kidney Institute and a co-author of the study, comments on the implications of these findings.
Which research results from the American Society for Radiation Oncology’s 2019 annual meeting are the most interesting or clinically relevant? The staff of Cleveland Clinic Cancer Center’s Department of Radiation Oncology picks their Top 10.
A study found that men who reported good preoperative understanding of their post-radical prostatectomy recovery had more accurate expectations and reported better sexual function outcomes than men who did not demonstrate good understanding presurgery.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The most prepared men were the most satisfied with recovery of postoperative urinary function and experiences surrounding surgery, and felt expectations had been met.
Does routine preoperative medical evaluation before radical prostatectomy justify the time and cost involved? New research reveals the impact of this type of evaluation on perioperative management and surgical outcomes.